{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:01:38Z","timestamp":1785823298265,"version":"3.56.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics: Clinical Practice"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jpedcp.2024.200121","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:42:18Z","timestamp":1720658538000},"page":"200121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A\u00a0US Expert Group Consensus"],"prefix":"10.1016","volume":"14","author":[{"given":"Mark","family":"Boguniewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moise L.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence F.","family":"Eichenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine T.","family":"Lauren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald Y.M.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda C.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine C.","family":"Siegfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wynnis L.","family":"Tom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Paller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpedcp.2024.200121_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.anai.2019.05.014","article-title":"The prevalence and persistence of atopic dermatitis in urban United States children","volume":"123","author":"McKenzie","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaad.2013.10.010","article-title":"Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis","volume":"70","author":"Eichenfield","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib3","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jaad.2021.10.038","article-title":"Prevalence of type 2 inflammatory diseases in pediatric patients with atopic dermatitis: real-world evidence","volume":"86","author":"Paller","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.anai.2019.04.020","article-title":"Comorbidities and the impact of atopic dermatitis","volume":"123","author":"Silverberg","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4168\/aair.2019.11.1.4","article-title":"Mechanisms by which atopic dermatitis predisposes to food allergy and the atopic March","volume":"11","author":"Tham","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jpedcp.2024.200121_bib6","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.jaip.2022.06.044","article-title":"Dietary Elimination for the treatment of atopic dermatitis: a systematic review and meta-analysis","volume":"10","author":"Oykhman","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jpedcp.2024.200121_bib7","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1016\/j.jaip.2021.04.064","article-title":"Sleep disturbance in school-aged children with atopic dermatitis: prevalence and severity in a cross-sectional Sample","volume":"9","author":"Fishbein","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jpedcp.2024.200121_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/pde.14889","article-title":"Parent report of sleep health and attention regulation in a cross-sectional study of infants and preschool-aged children with atopic dermatitis","volume":"39","author":"Zhou","year":"2022","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jpeds.2022.04.027","article-title":"The family impact of atopic dermatitis in the pediatric Population: results from an International cross-sectional study","volume":"246","author":"Barbarot","year":"2022","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpedcp.2024.200121_bib10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1525-1470.2005.22303.x","article-title":"The burden of atopic dermatitis: impact on the patient, family, and society","volume":"22","author":"Carroll","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib11","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-1102","article-title":"Recent developments in atopic dermatitis","volume":"142","author":"Yang","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpedcp.2024.200121_bib12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1542\/peds.2014-3678","article-title":"Translating atopic dermatitis management guidelines into practice for primary care providers","volume":"136","author":"Eichenfield","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpedcp.2024.200121_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.anai.2022.03.004","article-title":"Optimizing topical management of atopic dermatitis","volume":"128","author":"Butala","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.anai.2019.12.024","article-title":"Impact of atopic dermatitis treatment on child and parent sleep, daytime functioning, and quality of life","volume":"124","author":"Meltzer","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib15","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jaip.2020.12.007","article-title":"Sleep disturbances and atopic dermatitis: Relationships, methods for assessment, and therapies","volume":"9","author":"Bawany","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jpedcp.2024.200121_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.aller.2018.06.008","article-title":"Current therapeutic paradigm in pediatric atopic dermatitis: practical guidance from a national expert panel","volume":"47","author":"Chiricozzi","year":"2019","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/14656566.2018.1561868","article-title":"An update on the topical and oral therapy options for treating pediatric atopic dermatitis","volume":"20","author":"Glines","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jpedcp.2024.200121_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12895-020-00114-x","article-title":"Effects of variations in access to care for children with atopic dermatitis","volume":"20","author":"Siegfried","year":"2020","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib19","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/jdv.18345","article-title":"European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy","volume":"36","author":"Wollenberg","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/children6110125","article-title":"Topical and oral therapies for childhood atopic dermatitis and Plaque psoriasis","volume":"6","author":"Frantz","year":"2019","journal-title":"Children"},{"key":"10.1016\/j.jpedcp.2024.200121_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","article-title":"Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies","volume":"71","author":"Eichenfield","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaad.2020.03.075","article-title":"No evidence of increased cancer incidence in children using topical tacrolimus for atopic dermatitis","volume":"83","author":"Paller","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S2352-4642(22)00283-8","article-title":"Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis","volume":"7","author":"Devasenapathy","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jpedcp.2024.200121_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.anai.2020.08.016","article-title":"New treatments in atopic dermatitis","volume":"126","author":"Puar","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib28","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jaad.2021.06.014","article-title":"Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study","volume":"85","author":"Nakagawa","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2133.2010.10030.x","article-title":"Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials","volume":"164","author":"Schmitt","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib33","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jaad.2008.02.008","article-title":"Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle","volume":"58","author":"Breneman","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib34","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1136\/bmj.326.7403.1367","article-title":"Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study","volume":"326","author":"Berth-Jones","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jpedcp.2024.200121_bib35","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2133.2002.05006.x","article-title":"Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients","volume":"147","author":"Hanifin","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib36","doi-asserted-by":"crossref","first-page":"e1210","DOI":"10.1542\/peds.2008-1343","article-title":"Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use","volume":"122","author":"Paller","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpedcp.2024.200121_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jdin.2021.01.001","article-title":"Therapeutic education in atopic dermatitis: a position paper from the International Eczema Council","volume":"3","author":"Eichenfield","year":"2021","journal-title":"JAAD International"},{"key":"10.1016\/j.jpedcp.2024.200121_bib42","article-title":"Strategies for using topical corticosteroids in children and adults with eczema","volume":"3","author":"Lax","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpedcp.2024.200121_bib43","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1525-1470.2010.01223.x","article-title":"The safety and efficacy of tacrolimus ointment in pediatric patients with atopic dermatitis","volume":"27","author":"McCollum","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib44","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1016\/j.jaad.2005.04.062","article-title":"Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis","volume":"53","author":"Hanifin","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib45","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jaad.2022.09.060","article-title":"Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: results from two phase 3 studies","volume":"88","author":"Papp","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib46","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.anai.2022.12.033","article-title":"Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis","volume":"130","author":"Leung","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib47","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40257-023-00780-w","article-title":"Once-daily crisaborole ointment, 2%, as a long-term maintenance treatment in patients aged \u2265 3 Months with mild-to-moderate atopic dermatitis: a 52-week clinical study","volume":"24","author":"Eichenfield","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122767","article-title":"Novel therapeutic strategies in the topical treatment of atopic dermatitis","volume":"14","author":"Pinto","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpedcp.2024.200121_bib49","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jaip.2022.10.032","article-title":"Patients' and caregivers' experiences with atopic dermatitis-related burden, medical care, and treatments in 8 Countries","volume":"11","author":"Capozza","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jpedcp.2024.200121_bib50","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12912-020-00494-y","article-title":"The role of the nurse in the care and management of patients with atopic dermatitis","volume":"19","author":"van Os-Medendorp","year":"2020","journal-title":"BMC Nurs"},{"key":"10.1016\/j.jpedcp.2024.200121_bib52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/bjd.13084","article-title":"Psychodermatological aspects of atopic dermatitis","volume":"170","author":"Senra","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10061298","article-title":"Quality of life and psychological impact in patients with atopic dermatitis","volume":"10","author":"Talamonti","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jpedcp.2024.200121_bib54","article-title":"Psychological and educational interventions for atopic eczema in children","volume":"2014","author":"Ersser","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpedcp.2024.200121_bib55","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15273","article-title":"\"His first word was 'cream'.\" the burden of treatment in pediatric atopic dermatitis-A mixed methods study","volume":"35","author":"O'Connor","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jpedcp.2024.200121_bib56","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jdin.2022.12.008","article-title":"Factors facilitating shared decision making in eczema: Met and unmet needs from the patient perspective","volume":"11","author":"Foster","year":"2023","journal-title":"JAAD International"},{"key":"10.1016\/j.jpedcp.2024.200121_bib57","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.3399\/bjgp17X693617","article-title":"Developing a written action plan for children with eczema: a qualitative study","volume":"68","author":"Powell","year":"2018","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jpedcp.2024.200121_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaip.2018.10.021","article-title":"Strategies for successful management of severe atopic dermatitis","volume":"7","author":"Brar","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jpedcp.2024.200121_bib59","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.clindermatol.2018.05.003","article-title":"Developing an eczema action plan","volume":"36","author":"Levy","year":"2018","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib60","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jaip.2017.08.005","article-title":"Expert perspectives on management of moderate-to-severe atopic dermatitis: a multidisciplinary consensus addressing current and emerging therapies","volume":"5","author":"Boguniewicz","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jpedcp.2024.200121_bib61","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/CCID.S163814","article-title":"Treatment-resistant atopic dermatitis: challenges and solutions","volume":"12","author":"Johnson","year":"2019","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib62","doi-asserted-by":"crossref","first-page":"e023","DOI":"10.1097\/JW9.0000000000000023","article-title":"Recent insights into the management of treatment-resistant pediatric atopic dermatitis","volume":"8","author":"Naik","year":"2022","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib63","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/ajd.12331","article-title":"Factors contributing to poor treatment outcomes in childhood atopic dermatitis","volume":"56","author":"Sokolova","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7748\/ncyp.2023.e1459","article-title":"Atopic eczema and the barriers to treatment adherence for children: a literature review","volume":"35","author":"Brown","year":"2023","journal-title":"Nurs Child Young People"},{"key":"10.1016\/j.jpedcp.2024.200121_bib65","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s13555-022-00850-7","article-title":"Similarities and Differences in the Perception of atopic dermatitis burden between patients, caregivers, and independent physicians (AD-GAP Survey)","volume":"13","author":"Paller","year":"2023","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jpedcp.2024.200121_bib66","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/jcm4020231","article-title":"Interventions to increase treatment adherence in pediatric atopic dermatitis: a systematic review","volume":"4","author":"Bass","year":"2015","journal-title":"J Clin Med"},{"key":"10.1016\/j.jpedcp.2024.200121_bib67","first-page":"397","article-title":"A review of patient adherence to topical therapies for treatment of atopic dermatitis","volume":"96","author":"Snyder","year":"2015","journal-title":"Cutis"},{"key":"10.1016\/j.jpedcp.2024.200121_bib68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaad.2007.04.005","article-title":"Adherence to topical therapy increases around the time of office visits","volume":"57","author":"Feldman","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib69","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/09546630701441723","article-title":"The fingertip unit: a practical guide to topical therapy in children","volume":"18","author":"Kalavala","year":"2007","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jpedcp.2024.200121_bib70","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2230.1991.tb01232.x","article-title":"The finger-tip unit--a new practical measure","volume":"16","author":"Long","year":"1991","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib71","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/PHMT.S72461","article-title":"Treating pediatric atopic dermatitis: current perspectives","volume":"6","author":"Dimitriades","year":"2015","journal-title":"Pediatric Health Med Ther"},{"key":"10.1016\/j.jpedcp.2024.200121_bib72","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11096-019-00827-1","article-title":"Optimizing pharmaceutical care for pediatric patients with dermatitis: perspectives of parents and pharmacy staff","volume":"41","author":"Koster","year":"2019","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jpedcp.2024.200121_bib73","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/pde.13708","article-title":"Impact of pharmacists\u2019 counseling on caregiver's knowledge in the management of pediatric atopic dermatitis","volume":"36","author":"Cheong","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib75","author":"Wall"},{"key":"10.1016\/j.jpedcp.2024.200121_bib80","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s13555-021-00500-4","article-title":"Tolerability of and adherence to topical treatments in atopic dermatitis: a narrative review","volume":"11","author":"Tier","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jpedcp.2024.200121_bib81","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13052-022-01278-7","volume":"48","author":"Galli","year":"2022","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.jpedcp.2024.200121_bib82","doi-asserted-by":"crossref","first-page":"e378","DOI":"10.3399\/BJGP.2021.0503","article-title":"Supporting families managing childhood eczema: developing and optimising eczema care online using qualitative research","volume":"72","author":"Sivyer","year":"2022","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jpedcp.2024.200121_bib83","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1111\/jdv.15913","article-title":"A systematic review of factors influencing treatment adherence in chronic inflammatory skin disease \u2013 strategies for optimizing treatment outcome","volume":"33","author":"Eicher","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib84","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1097\/DER.0000000000000715","article-title":"Financial burden of atopic dermatitis out-of-pocket health care expenses in the United States","volume":"32","author":"Smith Begolka","year":"2021","journal-title":"Dermatitis"},{"key":"10.1016\/j.jpedcp.2024.200121_bib85","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2014.03.030","article-title":"Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents","volume":"71","author":"Sidbury","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib86","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/jamadermatol.2020.0796","article-title":"Systemic Immunomodulatory treatments for patients with atopic dermatitis: a systematic review and Network meta-analysis","volume":"156","author":"Drucker","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib87","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40272-022-00499-x","article-title":"Recent developments and Advances in atopic dermatitis: a focus on Epidemiology, Pathophysiology, and treatment in the pediatric setting","volume":"24","author":"Eichenfield","year":"2022","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jpedcp.2024.200121_bib88","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jaad.2017.06.042","article-title":"When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council","volume":"77","author":"Simpson","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib89","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13052-016-0229-8","article-title":"Consensus Conference on clinical management of pediatric atopic dermatitis","volume":"42","author":"Galli","year":"2016","journal-title":"Italian Journal of Pediatrics"},{"key":"10.1016\/j.jpedcp.2024.200121_bib90","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/bjd\/ljac116","article-title":"How we treat atopic dermatitis now and how that will change over the next 5 years","volume":"188","author":"Flohr","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib91","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jaad.2017.09.074","article-title":"A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis","volume":"78","author":"Yu","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib92","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13712","article-title":"Association of clinical and social factors with risk of fracture in children with atopic dermatitis","volume":"33","author":"Ha","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib93","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/bjd.15928","article-title":"Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement","volume":"178","author":"Drucker","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib94","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1007\/s13555-022-00829-4","article-title":"Current and emerging therapies in pediatric atopic dermatitis","volume":"12","author":"Johnson","year":"2022","journal-title":"Dermatology and Therapy"},{"key":"10.1016\/j.jpedcp.2024.200121_bib95","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/1203475420988866","article-title":"Caregiver preferences for the treatment of childhood atopic dermatitis","volume":"25","author":"Johnson","year":"2021","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jpedcp.2024.200121_bib96","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/jamadermatol.2013.2411","article-title":"Practice Gaps. Failing to clarify treatment action plans with mom in pediatric atopic dermatitis: comment on \"maternal adherence factors in the treatment of pediatric atopic dermatitis\"","volume":"149","author":"Levy","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib97","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0738-3991(99)00074-9","article-title":"Structured parent education in the management of childhood atopic dermatitis: the Berlin model","volume":"40","author":"Wenninger","year":"2000","journal-title":"Patient Educ Counsel"},{"key":"10.1016\/j.jpedcp.2024.200121_bib98","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/pai.12249","article-title":"Predictors of benefit from an atopic dermatitis education programme","volume":"25","author":"Breuer","year":"2014","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib100","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.7326\/M21-1757","article-title":"Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2 : a Prospective Cohort Study","volume":"174","author":"Deepak","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpedcp.2024.200121_bib101","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1016\/j.vaccine.2018.07.039","article-title":"The effect of immunosuppressive agents on immunogenicity of pneumococcal vaccination: a systematic review and meta-analysis","volume":"36","author":"van Aalst","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jpedcp.2024.200121_bib102","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.25033","article-title":"Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab","volume":"62","author":"van Assen","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpedcp.2024.200121_bib103","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jaad.2018.07.048","article-title":"Dupilumab does not affect correlates of vaccine-induced immunity: a randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis","volume":"80","author":"Blauvelt","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.711637","article-title":"Vaccination in children with Autoimmune disorders and treated with various immunosuppressive regimens: a comprehensive review and practical guide","volume":"12","author":"Blanchard-Rohner","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/1203475418811335","article-title":"Vaccination guidelines for patients with immune-Mediated disorders on immunosuppressive therapies","volume":"23","author":"Papp","year":"2019","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jpedcp.2024.200121_bib106","article-title":"Vaccinations and Autoimmune diseases","volume":"9","author":"Olivieri","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jpedcp.2024.200121_bib107","first-page":"660","article-title":"Managing eczema in children--a treatment update","volume":"60","author":"Dempster","year":"2011","journal-title":"J Fam Pract"},{"key":"10.1016\/j.jpedcp.2024.200121_bib108","doi-asserted-by":"crossref","first-page":"e1735","DOI":"10.1542\/peds.2014-2812","article-title":"Atopic dermatitis: skin-directed management","volume":"134","author":"Tollefson","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpedcp.2024.200121_bib109","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1080\/07853890.2021.2004322","article-title":"Dermatology for the internist: optimal diagnosis and management of atopic dermatitis","volume":"53","author":"Narla","year":"2021","journal-title":"Ann Med"},{"key":"10.1016\/j.jpedcp.2024.200121_bib110","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15259","article-title":"Good practice intervention for clinical assessment and diagnosis of atopic dermatitis: findings from the atopic dermatitis quality of care initiative","volume":"35","author":"Weidinger","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jpedcp.2024.200121_bib112","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.anai.2020.08.002","article-title":"The infectious complications of atopic dermatitis","volume":"126","author":"Wang","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib113","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/ijd.14941","article-title":"The clinical significance of fungi in atopic dermatitis","volume":"59","author":"Thammahong","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib114","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/bjd.18643","article-title":"The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group","volume":"182","author":"Alexander","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib115","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1365-4632.2012.05646.x","article-title":"Skin manifestations of nutritional deficiency disease in children: modern day contexts","volume":"51","author":"Lee","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib116","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2019.07.105","article-title":"Treatment patterns of pediatric patients with atopic dermatitis: a claims data analysis","volume":"82","author":"Paller","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jpedcp.2024.200121_bib117","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jpeds.2020.02.015","article-title":"Management of atopic dermatitis in children younger than two years of age by community pediatricians: a survey and chart review","volume":"221","author":"Fishbein","year":"2020","journal-title":"J Pediatr"}],"container-title":["The Journal of Pediatrics: Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950541024000279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950541024000279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T23:53:15Z","timestamp":1734133995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950541024000279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":99,"alternative-id":["S2950541024000279"],"URL":"https:\/\/doi.org\/10.1016\/j.jpedcp.2024.200121","relation":{},"ISSN":["2950-5410"],"issn-type":[{"value":"2950-5410","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A\u00a0US Expert Group Consensus","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics: Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpedcp.2024.200121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"200121"}}